Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...

In regard to what’s happening now with NIH, the main thing to do is diversify. You raise both non-dilutive funding through ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

Variations in regulatory requirements across regions often create inefficiencies in drug development—for example, differences in manufacturing standards and stability testing protocols can lead ...